# A Study of ALXN1840 (Coated and Non-coated) Administered With And Without Omeprazole In Healthy Adults

> **NCT05319912** · PHASE1 · COMPLETED · sponsor: **Alexion Pharmaceuticals, Inc.** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ALXN1840 Enteric-coated Tablet
- **DRUG:** ALXN1840 Non-coated Capsule
- **DRUG:** Omeprazole

## Key facts

- **NCT ID:** NCT05319912
- **Lead sponsor:** Alexion Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04-07
- **Primary completion:** 2014-05-29
- **Final completion:** 2014-05-29
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2023-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05319912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05319912, "A Study of ALXN1840 (Coated and Non-coated) Administered With And Without Omeprazole In Healthy Adults". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05319912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*